Bryan focuses his practice on health care, life sciences, and general corporate matters and often acts as outside general counsel for clients. He regularly advises a wide variety of health care businesses, including retail and specialty pharmacies, health systems, hospitals, medical practices, residential health providers, and drug, medical device, and dietary supplement manufacturers.

He advises clients on operational and compliance issues, risk mitigation strategies, FDA regulatory affairs, data privacy, mergers and acquisitions, vendor and customer agreements, and other sophisticated corporate transactions. He has strong practical experience on structuring and implementing complex care delivery models and assisting clients in developing and executing cutting edge strategic initiatives.

Further, Bryan is nationally recognized for his skills on the federal 340B drug pricing program and was recently named the National Law Review’s Go-To Thought Leader on 340B matters. His 340B Program-related work is critically important to the financial survival of safety net health care facilities, including disproportionate share hospitals, children’s hospitals, critical access hospitals, rural hospitals, and federal grantee clinics. Bryan is a committed partner of 340B Program stakeholders and leverages his deep experience in the 340B Program and Medicaid Drug Rebate Program to improve and protect his clients’ access to essential drug discounts.

Prior to joining Dinsmore, Bryan served as in-house counsel to a national specialty pharmacy and a Medicaid and Medicare managed care plan. His familiarity with the complexities of health care and life sciences industries, as well as his understanding of in-house legal needs, enables him to provide his clients professional and efficient legal advice.